Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jose Luis Relova"'
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
Autor:
Tania Cid‐Díaz, Saúl Leal‐López, Fátima Fernández‐Barreiro, Jessica González‐Sánchez, Icía Santos‐Zas, Luis J. Andrade‐Bulos, Manuel E. Rodríguez‐Fuentes, Carlos S. Mosteiro, Vincent Mouly, Xesús Casabiell, Jose Luis Relova, Yolanda Pazos, Jesus P. Camiña
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 493-505 (2021)
Abstract Background A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how t
Externí odkaz:
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
Autor:
Gustavo Fernández-Pajarín, Ángel Sesar, José Luis Relova, Begoña Ares, Isabel Jiménez, Miguel Gelabert-González, Eduardo Arán, Alfonso Castro
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 1001 (2022)
Background: The relationship between axial symptoms in Parkinson’s disease (PD) and subthalamic deep brain stimulation (STN-DBS) is still unclear. Purpose: We searched for particular clinical characteristics before STN-DBS linked to on-state axial
Externí odkaz:
https://doaj.org/article/5d7a234da12442daa2497927ff384138
Autor:
Jessica González‐Sánchez, Agustín Sánchez‐Temprano, Tania Cid‐Díaz, Regina Pabst‐Fernández, Carlos S. Mosteiro, Rosalía Gallego, Ruben Nogueiras, Xesús Casabiell, Gillian S. Butler‐Browne, Vincent Mouly, José Luis Relova, Yolanda Pazos, Jesús P. Camiña
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 6, Pp 1063-1078 (2018)
Abstract Background This study was performed to test the therapeutic potential of obestatin, an autocrine anabolic factor regulating skeletal muscle repair, to ameliorate the Duchenne muscular dystrophy (DMD) phenotype. Methods and results Using a mu
Externí odkaz:
https://doaj.org/article/ac85ac9944404db6b8a8d3a098d48356